Consequent genetic manipulation of the three kinases in mice led to the final identification of Csk inhibition, as the mechanism of ibrutinib-associated AF, as cardiac-specific Csk knockout in mice, mimicking ibrutinib treatment predisposed to increased AF, left atrial enlargement, fibrosis, and inflammation [49]. The gene discussed is CSK; the disease is atrial fibrillation.